rivaroxaban and Short-Bowel-Syndrome

rivaroxaban has been researched along with Short-Bowel-Syndrome* in 2 studies

Other Studies

2 other study(ies) available for rivaroxaban and Short-Bowel-Syndrome

ArticleYear
Rivaroxaban as anticoagulant therapy in short bowel syndrome. Report of three cases.
    Thrombosis research, 2015, Volume: 135, Issue:3

    Topics: Administration, Oral; Aged; Anticoagulants; Female; Humans; Male; Middle Aged; Rivaroxaban; Short Bowel Syndrome; Thrombosis

2015
Insufficient anticoagulation with dabigatran in a patient with short bowel syndrome.
    Thrombosis and haemostasis, 2014, Volume: 112, Issue:2

    Topics: Administration, Oral; Aged, 80 and over; Anticoagulants; Atrial Fibrillation; Benzimidazoles; Biological Availability; Blood Coagulation; Dabigatran; Drug Monitoring; Drug Substitution; Factor Xa Inhibitors; Female; Humans; Infarction, Middle Cerebral Artery; Intestinal Absorption; Morpholines; Predictive Value of Tests; Pyridines; Risk Factors; Rivaroxaban; Short Bowel Syndrome; Thiophenes; Treatment Outcome

2014